Lab guide · Comparisons
GHRH vs GHRP: Two Receptor Classes That Control Growth Hormone Release
GHRH vs GHRP is a comparison between two families of peptides that trigger growth hormone release through different receptors on the same pituitary cells. GHRH and its analogues, such as sermorelin and CJC-1295, act on the GHRH receptor, while GHRPs such as ipamorelin and GHRP-6 act on the ghrelin receptor GHS-R1a. This guide sets out the seven differences and the evidence for why the two classes are studied together.
Key takeaways
- GHRH analogues (sermorelin, CJC-1295) act on the GHRH receptor; GHRPs (ipamorelin, GHRP-6) act on the ghrelin receptor GHS-R1a.
- The GHS receptor was cloned in 1996 and its natural ligand, ghrelin, was found in 1999, so GHRPs were discovered before their receptor was known.
- In several species, combining a GHRP with GHRH produced a supra-additive GH response in vivo, under specific dose conditions.
- Ipamorelin was reported as the first GHRP-receptor agonist with GH selectivity similar to GHRH, without the ACTH and cortisol rise seen with GHRP-6 and GHRP-2.
GHRH vs GHRP at a glance
| # | Feature | GHRH and analogues | GHRPs |
|---|---|---|---|
| 1 | Receptor | GHRH receptor | Ghrelin receptor GHS-R1a |
| 2 | Chemical class | 29-44 residue peptides | Small peptides of 5-6 residues |
| 3 | Series examples | Sermorelin, CJC-1295 with and without DAC | Ipamorelin (and GHRP-6 as the reference compound) |
| 4 | Discovery | GHRH is the hypothalamic hormone; analogues designed from it | Synthetic compounds found first; receptor cloned in 1996, ghrelin in 1999 |
| 5 | Main signal | cAMP via a G protein-coupled receptor | Calcium signalling via GHS-R1a |
| 6 | Selectivity | Selective for GH release | Varies: GHRP-6 and GHRP-2 raised ACTH and cortisol; ipamorelin did not |
| 7 | Combined effect | Supra-additive GH release with a GHRP in several species | Same |
Research use only. This comparison summarises published laboratory and clinical-pharmacology research. Baltic Peptides supplies these compounds for in-vitro and preclinical research by qualified researchers; they are not medicines and are not for human or veterinary use.
The GHRH class
Growth hormone-releasing hormone is the hypothalamic hormone that stimulates GH secretion from the pituitary through its receptor, a G protein-coupled receptor of the pituitary type, as set out in a review of GHRH receptor signalling. Analogues such as sermorelin (GHRH 1-29) and CJC-1295 are variants of the first 29 residues. See What is Sermorelin and CJC-1295 with DAC vs without DAC.
The GHRP class
A historical review of synthetic GHRPs reports that the family of synthetic GH secretagogues came to light when Cyril Bowers observed that chemical analogues of enkephalin amide had GH-releasing activity in pituitary cultures, and that GHRP-6 was the first synthetic peptide to specifically elicit dose-related GH release in vitro and in vivo. The same review says GHRPs bind two receptors, GHS-R1a and CD36. A review of the GHRP field records that the GHS receptor was cloned in 1996, in the anterior pituitary and in the brain, and that its natural ligand, ghrelin, was discovered in 1999 (Brazilian Journal of Medical and Biological Research).
Selectivity: the ipamorelin finding
Raun et al. (1998) described ipamorelin as a pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, with GH-releasing potency and efficacy similar to GHRP-6 in rat pituitary cells (EC50 1.3 versus 2.2 nmol/L). Profiling with GHRP and GHRH antagonists showed that ipamorelin, like GHRP-6, acts through a GHRP-like receptor. In swine, none of the secretagogues affected FSH, LH, PRL or TSH, and GHRP-6 and GHRP-2 raised ACTH and cortisol, but ipamorelin did not, even at doses more than 200-fold above its ED50 for GH release. The authors concluded that it was the first GHRP-receptor agonist with selectivity for GH release similar to GHRH.
Why the two classes are studied together
The review of the ghrelin system states that ghrelin or synthetic GH secretagogues achieve synergy with GHRH, meaning supra-additive stimulation of GH secretion, when a near-threshold dose of the secretagogue is combined with a maximally effective dose of GHRH in the human, rat, pig, cow and dog in vivo. Synergism was not observed when maximal doses of both were combined, nor with submaximal GHRH plus maximal secretagogue. A 2008 study further found that GHRH can interact with the ghrelin receptor GHS-R1a and modify ghrelin-associated signalling.
This evidence concerns specific combinations and dose conditions in the cited species. It does not describe a particular commercial blend. See CJC-1295 vs Ipamorelin and peptide blends explained.
Limits of this comparison
- The synergy evidence depends on dose conditions and species, and cannot be assumed for a given mixture.
- Selectivity findings for ipamorelin come from a 1998 animal study.
- Classification of a compound as GHRH-type or GHRP-type says nothing about its purity or identity, which need testing.
- Both classes are prohibited in sport by WADA and neither is approved for research-grade supply.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page.
Sources and further reading
- Raun K. et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 139(5):552-561. PubMed
- Synthetic growth hormone-releasing peptides (GHRPs): a historical appraisal (2017). PMC
- Integrating GHS into the ghrelin system (review). PMC
- Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a (2008). PMC
- Growth hormone-releasing hormone receptor (GHRH-R) and its signaling (2025 review). PMC
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article explains analytical and chemical concepts and is for educational purposes only.
FAQ
Common questions
What is the difference between GHRH and GHRP?
Is ipamorelin a GHRH or a GHRP?
Are sermorelin and CJC-1295 GHRH analogues?
Why was GHRP-6 discovered before its receptor?
Do GHRH and GHRP work together?
Why is ipamorelin called selective?
Does evidence for GHRH plus GHRP apply to commercial blends?
Keep reading
Related reading
CJC-1295 with DAC vs without DAC
Albumin binding and half-life of the two forms.
What is Ipamorelin?
The selective GHRP and its structure.
Peptide blends explained
Why component evidence does not define a mixture.
Research-grade GH-axis compounds, tested before they ship
Independent HPLC and mass spec results for every batch, dispatched from the EU.
